Neovastat (Æ-941) in refractory renal cell carcinoma patients: report of a phase II trial with two dose levels
| Autor: | Batist, G. *, Patenaude, F., Champagne, P., Croteau, D., Levinton, C., Hariton, C., Escudier, B., Dupont, E. |
|---|---|
| Zdroj: | In Annals of Oncology August 2002 13(8):1259-1263 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|